{
    "organizations": [],
    "uuid": "7de31d884ba1daa38d6f8447276a128d0054a0f5",
    "author": "cnbc.com",
    "url": "https://www.cnbc.com/2018/03/05/the-associated-press-fate-therapeutics-reports-4q-loss.html",
    "ord_in_thread": 0,
    "title": "Fate Therapeutics reports 4Q loss",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "SAN DIEGO (AP) _ Fate Therapeutics Inc. (FATE) on Monday reported a loss of $12.5 million in its fourth quarter.\nOn a per-share basis, the San Diego-based company said it had a loss of 29 cents.\nThe results missed Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for a loss of 24 cents per share.\nThe clinical-stage biotech company that develops stem cell treatments posted revenue of $1 million in the period, meeting Street forecasts.\nFor the year, the company reported that its loss widened to $43 million, or $1.02 per share. Revenue was reported as $4.1 million.\nFate Therapeutics shares have more than doubled since the beginning of the year. In the final minutes of trading on Monday, shares hit $13.83, more than tripling in the last 12 months.\nThis story was generated by Automated Insights ( http://automatedinsights.com/ap ) using data from Zacks Investment Research. Access a Zacks stock report on FATE at https://www.zacks.com/ap/FATE",
    "published": "2018-03-05T23:15:00.000+02:00",
    "crawled": "2018-03-06T02:09:05.016+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "san",
        "diego",
        "ap",
        "fate",
        "therapeutic",
        "fate",
        "monday",
        "reported",
        "loss",
        "million",
        "fourth",
        "quarter",
        "basis",
        "san",
        "company",
        "said",
        "loss",
        "cent",
        "result",
        "missed",
        "wall",
        "street",
        "expectation",
        "average",
        "estimate",
        "five",
        "analyst",
        "surveyed",
        "zacks",
        "investment",
        "research",
        "loss",
        "cent",
        "per",
        "share",
        "biotech",
        "company",
        "develops",
        "stem",
        "cell",
        "treatment",
        "posted",
        "revenue",
        "million",
        "period",
        "meeting",
        "street",
        "forecast",
        "year",
        "company",
        "reported",
        "loss",
        "widened",
        "million",
        "per",
        "share",
        "revenue",
        "reported",
        "million",
        "fate",
        "therapeutic",
        "share",
        "doubled",
        "since",
        "beginning",
        "year",
        "final",
        "minute",
        "trading",
        "monday",
        "share",
        "hit",
        "tripling",
        "last",
        "month",
        "story",
        "generated",
        "automated",
        "insight",
        "http",
        "using",
        "data",
        "zacks",
        "investment",
        "research",
        "access",
        "zacks",
        "stock",
        "report",
        "fate",
        "http"
    ]
}